Samuel T Ruzzene, Vinicius P Garcia, Auburn R Berry, Madeleine F Stone, Kendra N Wegerson, Emily I Ostrander, Hannah K Fandl, Jared J Greiner, Andrew J Park, Brian L Stauffer, Christopher A DeSouza
{"title":"Obesity-related circulating endothelial extracellular vesicles negatively affect cerebral microvascular cell function.","authors":"Samuel T Ruzzene, Vinicius P Garcia, Auburn R Berry, Madeleine F Stone, Kendra N Wegerson, Emily I Ostrander, Hannah K Fandl, Jared J Greiner, Andrew J Park, Brian L Stauffer, Christopher A DeSouza","doi":"10.1152/ajpendo.00128.2026","DOIUrl":null,"url":null,"abstract":"<p><p>The aim of this study was to determine, in vitro, the effect of endothelial cell-derived extracellular vesicles (EEVs) from adults with obesity on brain microvascular endothelial cell nitric oxide (NO) and endothelin (ET)-1 production as well as tissue-type plasminogen activator (t-PA) release. Circulating EEVs (CD144+ extracellular vesicles) were identified, enumerated, and isolated (flow cytometry) from 24 midlife and older sedentary adults (45-71 yr): 12 normal weight [6 M/6 F; body mass index (BMI) ≥18.5 and ≤25 kg/m<sup>2</sup>] adults and 12 adults with obesity (6 M/6 F; BMI ≥ 30.0 kg/m<sup>2</sup>). Human cerebral microvascular endothelial cells (hCMECs) were cultured and treated with EEVs from either normal-weight adults or adults with obesity. Expression of phosphorylated (p)-eNOS (Ser1177) was ∼20% lower (31.5 ± 5.6 vs. 39.1 ± 7.9 AU) and p-eNOS (Thr495) expression ∼40% higher (47.3 ± 13.2 vs. 33.4 ± 10.5 AU) in hCMECs treated with EEVs from obese compared with normal weight adults. As a result, NO production was significantly lower (∼20%) in hCMECs treated with EEVs from adults with obesity (4.9 ± 0.4 vs. 5.9 ± 0.5 µmol/L). Cell expression of Big ET-1 (317.8 ± 51.8 vs. 241.6 ± 65.0 AU) and endothelin-converting enzyme (838.3 ± 160.8 vs. 631.8 ± 126.3 AU) as well as ET-1 production (21.9 ± 1.6 vs. 18.0 ± 3.9 pg/mL) were significantly higher in hCMECs treated with EEVs from adults with obesity. t-PA release in response to thrombin was significantly lower in hCMECs treated with EEVs from obese (from 49.3 ± 6.6 to 52.3 ± 8.2 pg/mL) compared with normal weight (from 52.3 ± 8.8 to 62.0 ± 8.1 pg/mL) adults. Circulating EEVs are a potential mediator of obesity-related cerebrovascular dysfunction and stroke risk.<b>NEW & NOTEWORTHY</b> Despite an improved understanding of many of the pathological consequences associated with human obesity, factors that initiate, promote, and accelerate cerebrovascular events are not completely understood. This study provides novel data demonstrating that circulating EEVs from adults with obesity adversely affect eNOS activity, reducing nitric oxide bioavailability, enhancing ET-1 production, and impairing t-PA release in brain microvascular endothelial cells in vitro. These changes in endothelial cell phenotype have been linked with cerebrovascular dysfunction and ischemic stroke risk.</p>","PeriodicalId":7594,"journal":{"name":"American journal of physiology. Endocrinology and metabolism","volume":" ","pages":"E165-E173"},"PeriodicalIF":4.2000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of physiology. Endocrinology and metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1152/ajpendo.00128.2026","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/2 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
The aim of this study was to determine, in vitro, the effect of endothelial cell-derived extracellular vesicles (EEVs) from adults with obesity on brain microvascular endothelial cell nitric oxide (NO) and endothelin (ET)-1 production as well as tissue-type plasminogen activator (t-PA) release. Circulating EEVs (CD144+ extracellular vesicles) were identified, enumerated, and isolated (flow cytometry) from 24 midlife and older sedentary adults (45-71 yr): 12 normal weight [6 M/6 F; body mass index (BMI) ≥18.5 and ≤25 kg/m2] adults and 12 adults with obesity (6 M/6 F; BMI ≥ 30.0 kg/m2). Human cerebral microvascular endothelial cells (hCMECs) were cultured and treated with EEVs from either normal-weight adults or adults with obesity. Expression of phosphorylated (p)-eNOS (Ser1177) was ∼20% lower (31.5 ± 5.6 vs. 39.1 ± 7.9 AU) and p-eNOS (Thr495) expression ∼40% higher (47.3 ± 13.2 vs. 33.4 ± 10.5 AU) in hCMECs treated with EEVs from obese compared with normal weight adults. As a result, NO production was significantly lower (∼20%) in hCMECs treated with EEVs from adults with obesity (4.9 ± 0.4 vs. 5.9 ± 0.5 µmol/L). Cell expression of Big ET-1 (317.8 ± 51.8 vs. 241.6 ± 65.0 AU) and endothelin-converting enzyme (838.3 ± 160.8 vs. 631.8 ± 126.3 AU) as well as ET-1 production (21.9 ± 1.6 vs. 18.0 ± 3.9 pg/mL) were significantly higher in hCMECs treated with EEVs from adults with obesity. t-PA release in response to thrombin was significantly lower in hCMECs treated with EEVs from obese (from 49.3 ± 6.6 to 52.3 ± 8.2 pg/mL) compared with normal weight (from 52.3 ± 8.8 to 62.0 ± 8.1 pg/mL) adults. Circulating EEVs are a potential mediator of obesity-related cerebrovascular dysfunction and stroke risk.NEW & NOTEWORTHY Despite an improved understanding of many of the pathological consequences associated with human obesity, factors that initiate, promote, and accelerate cerebrovascular events are not completely understood. This study provides novel data demonstrating that circulating EEVs from adults with obesity adversely affect eNOS activity, reducing nitric oxide bioavailability, enhancing ET-1 production, and impairing t-PA release in brain microvascular endothelial cells in vitro. These changes in endothelial cell phenotype have been linked with cerebrovascular dysfunction and ischemic stroke risk.
本研究的目的是在体外确定肥胖成人内皮细胞来源的细胞外囊泡(EEVs)对脑微血管内皮细胞一氧化氮(NO)和内皮素(ET)-1产生以及组织型纤溶酶原激活剂(t-PA)释放的影响。循环eev (CD144+细胞外囊泡)被鉴定、枚举和分离(流式细胞术)来自24名中年和老年久坐成年人(45-71岁):12名正常体重(6 M/6F;体重指数(BMI)≥18.5且≤25 kg/m2)的成年人和12名肥胖成年人(6 M/6F; BMI≥30.0 kg/m2)。培养人大脑微血管内皮细胞(hCMECs),并分别用正常体重成人和肥胖成人的脑膜内皮细胞处理。与正常体重的成年人相比,肥胖eev治疗的hCMECs中磷酸化(p)-eNOS (Ser1177)的表达降低了约20% (31.5+5.6 v vs 39.1+7.9 AU), p-eNOS (Thr495)的表达提高了约40% (47.3+13.2 vs 33.4+10.5 AU)。结果,肥胖成人eev处理的hCMECs NO产量显著降低(约20%)(4.9+0.4 vs 5.9+0.5µmol/L)。在肥胖成人eev治疗的hCMECs中,细胞表达大ET-1 (317.8+51.8 vs 241.6+65.0 AU)和内皮素转换酶(838.3+160.8 vs 631.8+126.3 AU)以及ET-1产量(21.9+1.6 vs 18.0+3.9 pg/mL)显著升高。与正常体重成人(从52.3+8.8到62.0+8.1 pg/mL)相比,肥胖eev治疗的hCMECs对凝血酶的t-PA释放明显降低(从49.3+6.6到52.3+8.2 pg/mL)。循环EEVs是肥胖相关脑血管功能障碍和卒中风险的潜在中介。
期刊介绍:
The American Journal of Physiology-Endocrinology and Metabolism publishes original, mechanistic studies on the physiology of endocrine and metabolic systems. Physiological, cellular, and molecular studies in whole animals or humans will be considered. Specific themes include, but are not limited to, mechanisms of hormone and growth factor action; hormonal and nutritional regulation of metabolism, inflammation, microbiome and energy balance; integrative organ cross talk; paracrine and autocrine control of endocrine cells; function and activation of hormone receptors; endocrine or metabolic control of channels, transporters, and membrane function; temporal analysis of hormone secretion and metabolism; and mathematical/kinetic modeling of metabolism. Novel molecular, immunological, or biophysical studies of hormone action are also welcome.